# A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Emboli

Source: https://onco.cc/trials/nct07333287/  
OnCo record `nct07333287` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial in pancreatic cancer, run by Shandong Provincial Hospital, not yet recruiting.

## Summary

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors. is a phase 2, interventional study registered as NCT07333287 by Shandong Provincial Hospital, with a registry enrolment figure of 38 participants, started 2026-02-01 and due to reach its primary completion in 2027-02-28. Interventions recorded: Interventional; Targeted Therapy (anti-VEGF); Immunotherapy + Targeted Therapy; Immunotherapy + Targeted Therapy + Chemotherapy; This cycle is repeated every 21 days.. Conditions listed: Pancreatic Cancer Liver Metastases; Immunotherapy-naive. Primary outcome: Progression-Free Survival（PFS）. Pancreatic eligibility wording from the registry: "Histologically or cytologically confirmed, previously untreated unresectable pancreatic ductal adenocarcinoma with liver metastases (TNM stage: IV)". No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT07333287
- Phase: 2
- Setting: A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.
- Sponsor: Shandong Provincial Hospital
- Enrolled: 38

## Sources

- ClinicalTrials.gov NCT07333287: https://clinicaltrials.gov/study/NCT07333287

## Connected records

- cancers: [Locally advanced unresectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/locally-advanced-pdac/), [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07333287.json